Organization
Filip Krag Knop
3 clinical trials
Clinical trial
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes: A Randomized, Double-blind, Placebo-controlled, Investigator-initiated TrialStatus: Recruiting, Estimated PCD: 2026-06-15
Clinical trial
Ready-to-use Dasiglucagon for the Treatment of Postprandial Hypoglycaemia in Roux-en-Y Gastric Bypass Operated PatientsStatus: Completed, Estimated PCD: 2022-05-15